GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 119,800
-7,100 (-5.59%)
Last updated: Jun 8, 2026, 2:03 PM KST
GC Biopharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,448,326 | 1,814,695 | 2,048,665 | 1,432,354 | 1,478,007 | 2,488,073 | |
Market Cap Growth | 6.64% | -11.42% | 43.03% | -3.09% | -40.60% | -46.30% |
Enterprise Value | 2,400,213 | 2,959,257 | 3,129,049 | 2,368,951 | 2,204,898 | 3,075,936 |
Last Close Price | 126900.00 | 157420.53 | 177716.89 | 123165.91 | 125551.64 | 208663.39 |
PE Ratio | - | - | - | - | 22.58 | 20.19 |
Forward PE | 16.36 | 28.99 | 87.99 | 47.35 | 21.09 | 25.00 |
PS Ratio | 0.71 | 0.91 | 1.22 | 0.88 | 0.86 | 1.62 |
PB Ratio | 1.11 | 1.30 | 1.38 | 0.93 | 0.94 | 1.66 |
P/TBV Ratio | 1.61 | 1.86 | 1.94 | 1.34 | 1.33 | 2.31 |
P/FCF Ratio | 22.02 | 66.96 | - | - | 24.17 | 105.17 |
P/OCF Ratio | 8.99 | 18.25 | - | - | 12.40 | 19.75 |
PEG Ratio | - | 1.35 | 1.35 | 1.35 | 1.35 | 1.20 |
EV/Sales Ratio | 1.17 | 1.49 | 1.86 | 1.46 | 1.29 | 2.00 |
EV/EBITDA Ratio | 10.15 | 19.04 | 27.67 | 21.57 | 15.12 | 23.73 |
EV/EBIT Ratio | 16.19 | 43.64 | 97.66 | 69.86 | 27.32 | 41.72 |
EV/FCF Ratio | 36.50 | 109.20 | - | - | 36.05 | 130.02 |
Debt / Equity Ratio | 0.70 | 0.70 | 0.56 | 0.47 | 0.37 | 0.40 |
Debt / EBITDA Ratio | 5.72 | 6.32 | 7.32 | 6.59 | 3.95 | 4.68 |
Debt / FCF Ratio | 13.90 | 36.24 | - | - | 9.41 | 25.64 |
Net Debt / Equity Ratio | 0.67 | 0.67 | 0.54 | 0.43 | 0.30 | 0.27 |
Net Debt / EBITDA Ratio | 5.46 | 5.99 | 7.11 | 6.09 | 3.18 | 3.11 |
Net Debt / FCF Ratio | 13.25 | 34.37 | -9.41 | -7.91 | 7.57 | 17.06 |
Asset Turnover | 0.71 | 0.70 | 0.62 | 0.63 | 0.69 | 0.67 |
Inventory Turnover | 1.71 | 1.76 | 1.90 | 2.38 | 2.52 | 2.28 |
Quick Ratio | 0.40 | 0.40 | 0.55 | 0.58 | 0.96 | 1.13 |
Current Ratio | 1.25 | 1.20 | 1.56 | 1.20 | 1.81 | 1.97 |
Return on Equity (ROE) | -2.29% | -2.07% | -2.82% | -1.27% | 4.53% | 9.89% |
Return on Assets (ROA) | 1.54% | 1.48% | 0.74% | 0.82% | 2.02% | 2.00% |
Return on Invested Capital (ROIC) | 3.18% | 2.94% | 1.43% | 1.60% | 3.32% | 3.36% |
Return on Capital Employed (ROCE) | 4.10% | 3.70% | 1.60% | 1.90% | 4.10% | 3.90% |
Earnings Yield | -0.96% | -0.26% | -1.28% | -1.86% | 4.43% | 4.95% |
FCF Yield | 4.54% | 1.49% | -4.17% | -5.90% | 4.14% | 0.95% |
Dividend Yield | 1.18% | 0.95% | - | - | - | - |
Payout Ratio | - | - | - | - | 36.65% | 15.02% |
Buyback Yield / Dilution | -0.00% | - | 0.00% | - | - | - |
Total Shareholder Return | 1.18% | 0.95% | - | - | - | - |